Zimmer Biomet stock hits 52-week low at $79.83

Zimmer Biomet Holdings Inc. (ZBH) stock dropped to a 52-week low of $79.83, reflecting a 12.62% decline over the past year despite recent strong Q1 2026 financial results that surpassed expectations. While InvestingPro suggests the stock is undervalued and management is aggressively buying back shares, analysts have adjusted price targets downwards due to market complexity and perceived execution risks. The company has, however, maintained dividend payments for 15 consecutive years.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin